Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review

• by Michiel A van Nieuwenhoven

• July 13, 2026

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

• by Kathryn Wighton

• February 18, 2026

• 3 min

Diagnostic performance of fecal eosinophil-derived neurotoxin and lipocalin-2 in pediatric inflammatory bowel disease

• by Ragaey Ahmad Eid, Nada Atteya Fakhry, Doaa Mabrouk Ahmed, Mahmoud Hodeib

• July 17, 2026

Link Between Blastocystis Subtypes 3 and 4 and Intestinal Inflammation as Well as Metronidazole Efficacy in Symptomatic Individuals

• by Noha M. Amin, Amira R. Ismail, Shimaa M. Abdel Aal, Aly ELkazaz, Hala Ramadan, Ahmed Mohamed Shenawy, Shaimaa Mohamed Ali, Shimaa Saad El-Din, Magda SA Abdeltawab

• April 1, 2026